VIIV HLTHCARE FDA Approval NDA 020518

NDA 020518

VIIV HLTHCARE

FDA Drug Application

Application #020518

Documents

Letter2002-02-21
Letter2002-12-18
Letter2006-05-18
Letter2006-12-04
Letter2008-09-23
Label2006-05-16
Label2008-09-25
Label2009-11-23
Review2005-04-19
Letter2001-03-30
Letter2004-03-11
Letter2010-01-06
Letter2010-05-21
Letter2011-12-01
Letter2012-06-04
Letter2014-12-31
Label2001-03-30
Label2003-04-25
Label2003-04-04
Label2004-03-11
Label2006-11-22
Label2010-05-18
Label2011-11-25
Label2012-06-06
Label2015-01-08

Application Sponsors

NDA 020518VIIV HLTHCARE

Marketing Status

Discontinued001
Discontinued002

Application Products

001TABLET;ORAL200MG0RETROVIRZIDOVUDINE
002TABLET;ORAL300MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1RETROVIRZIDOVUDINE

FDA Submissions

TYPE 3; Type 3 - New Dosage FormORIG1AP1995-12-19STANDARD
LABELING; LabelingSUPPL2AP1998-03-04STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1998-06-12STANDARD
LABELING; LabelingSUPPL4AP2001-03-30STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1999-02-26STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL6AP1999-04-02STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL7AP2000-02-01STANDARD
LABELING; LabelingSUPPL8AP2001-10-05STANDARD
LABELING; LabelingSUPPL9AP2002-02-21STANDARD
LABELING; LabelingSUPPL10AP2002-12-18STANDARD
LABELING; LabelingSUPPL11AP2003-10-15STANDARD
LABELING; LabelingSUPPL13AP2006-05-10STANDARD
LABELING; LabelingSUPPL15AP2006-11-20STANDARD
EFFICACY; EfficacySUPPL16AP2008-09-19UNKNOWN
LABELING; LabelingSUPPL18AP2009-11-06STANDARD
LABELING; LabelingSUPPL19AP2010-05-17STANDARD
LABELING; LabelingSUPPL22AP2011-11-18901 REQUIRED
LABELING; LabelingSUPPL23AP2012-05-31STANDARD
LABELING; LabelingSUPPL24AP2014-12-23STANDARD

Submissions Property Types

SUPPL1Null0
SUPPL3Null0
SUPPL5Null0
SUPPL6Null0
SUPPL7Null0
SUPPL16Null6
SUPPL18Null7
SUPPL19Null7
SUPPL22Null6
SUPPL23Null7
SUPPL24Null7

CDER Filings

VIIV HLTHCARE
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 20518
            [companyName] => VIIV HLTHCARE
            [docInserts] => ["",""]
            [products] => [{"drugName":"RETROVIR","activeIngredients":"ZIDOVUDINE","strength":"200MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"RETROVIR","activeIngredients":"ZIDOVUDINE","strength":"300MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"}]
            [labels] => [{"actionDate":"12\/23\/2014","submission":"SUPPL-24","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/019910s041lbl.pdf\"}]","notes":""},{"actionDate":"05\/31\/2012","submission":"SUPPL-23","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2012\\\/019655s053,019910s040,020518s023lbl.pdf\"}]","notes":""},{"actionDate":"11\/18\/2011","submission":"SUPPL-22","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2011\\\/019655s052,019910s039,020518s022lbl.pdf\"}]","notes":""},{"actionDate":"05\/17\/2010","submission":"SUPPL-19","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2010\\\/020518s019lbl.pdf\"}]","notes":""},{"actionDate":"11\/06\/2009","submission":"SUPPL-18","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2009\\\/019655s048,020518s018lbl.pdf\"}]","notes":""},{"actionDate":"09\/19\/2008","submission":"SUPPL-16","supplementCategories":"Efficacy-New Dosing Regimen","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2008\\\/019910s033,019655s046,020518s016lbl.pdf\"}]","notes":""},{"actionDate":"11\/20\/2006","submission":"SUPPL-15","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2006\\\/020518s015lbl.pdf\"}]","notes":""},{"actionDate":"05\/10\/2006","submission":"SUPPL-13","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2006\\\/019655s41,019910s29,020518s13lbl.pdf\"}]","notes":""},{"actionDate":"10\/15\/2003","submission":"SUPPL-11","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2003\\\/19655slr039,19910slr027,20518slr011_retrovir_lbl.pdf\"}]","notes":""},{"actionDate":"12\/18\/2002","submission":"SUPPL-10","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2002\\\/20518slr010,19910slr026,19655slr038_retrovir_lbl.pdf\"}]","notes":""},{"actionDate":"10\/05\/2001","submission":"SUPPL-8","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2001\\\/20518s8lbl.pdf\"}]","notes":""},{"actionDate":"03\/30\/2001","submission":"SUPPL-4","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2001\\\/20518S4lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"RETROVIR","submission":"ZIDOVUDINE","actionType":"200MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"},{"actionDate":"RETROVIR","submission":"ZIDOVUDINE","actionType":"300MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 2014-12-23
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.